Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2021 Filed Oct 18, 2021 22:53 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GiftCommon Stock | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060756 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,212 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 22:22 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,336 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001209191-21-055362 · doc4.xml · derivative · entry 3 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,664 Underlying: Common Stock · 7,336 shares Expires 2026-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the "Option Anniversary Date") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 22:22 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
SaleCommon Stock | 7,336 | $100.65 | $738,368.40 |
DisclosureSEC source: 0001209191-21-055362 · doc4.xml · nonDerivative · entry 2 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,668 F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 22:22 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
Exercise / conversionCommon Stock | 7,336 | $54.50 | $399,812.00 |
DisclosureSEC source: 0001209191-21-055362 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $55.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · derivative · entry 6 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 2,500 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on January 30, 2019 (the first anniversary of the grant date of the option or the "Option Anniversary Date") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option will fully vest on the fourth anniversary of the grant date. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 2,500 | $100.18 | $250,450.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · nonDerivative · entry 4 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,775 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,500 | $55.00 | $137,500.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · nonDerivative · entry 3 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $55.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · derivative · entry 5 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,500 Underlying: Common Stock · 2,500 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on January 30, 2019 (the first anniversary of the grant date of the option or the "Option Anniversary Date") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option will fully vest on the fourth anniversary of the grant date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 2,500 | $100.03 | $250,075.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · nonDerivative · entry 2 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,775 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:11 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,500 | $55.00 | $137,500.00 |
DisclosureSEC source: 0001209191-21-054542 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 15:56 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 375 | $91.53 | $34,323.75 |
DisclosureSEC source: 0001209191-21-045972 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,333 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 23:58 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,255 | $0.00 Strike: $96.29 | $0.00 |
DisclosureSEC source: 0001209191-21-044165 · doc4.xml · derivative · entry 2 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,255 Underlying: Common Stock · 7,255 shares Expires 2031-06-29 F2 · derivative.exercise_date: The option shall vest with respect to 1/36th of the shares monthly such that the option shall fully vest on the third anniversary of the grant date. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 23:58 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantCommon Stock | 3,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044165 · doc4.xml · nonDerivative · entry 1 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,895 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:27 UTC |
WELCH DANIEL GDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043549 · doc4.xml · derivative · entry 2 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:27 UTC |
WELCH DANIEL GDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043549 · doc4.xml · nonDerivative · entry 1 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,445 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:25 UTC |
Dunsire DeborahDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043545 · doc4.xml · derivative · entry 2 Dunsire Deborah · CIK 0001332764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:25 UTC |
Dunsire DeborahDirector
|
GrantCommon stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043545 · doc4.xml · nonDerivative · entry 1 Dunsire Deborah · CIK 0001332764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,570 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:23 UTC |
NARACHI MICHAELDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043538 · doc4.xml · derivative · entry 2 NARACHI MICHAEL · CIK 0001380022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:23 UTC |
NARACHI MICHAELDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043538 · doc4.xml · nonDerivative · entry 1 NARACHI MICHAEL · CIK 0001380022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,445 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:24 UTC |
Ekman LarsDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043543 · doc4.xml · derivative · entry 2 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:24 UTC |
Ekman LarsDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043543 · doc4.xml · nonDerivative · entry 1 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,445 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:24 UTC |
Fust Matthew KDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043540 · doc4.xml · derivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:24 UTC |
Fust Matthew KDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043540 · doc4.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,695 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:26 UTC |
Aliski WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043547 · doc4.xml · derivative · entry 4 Aliski William · CIK 0001598426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F4 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:26 UTC |
Aliski WilliamDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043547 · doc4.xml · nonDerivative · entry 1 Aliski William · CIK 0001598426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,849 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:22 UTC |
SULIMAN SHEHNAAZDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $93.20 | $0.00 |
DisclosureSEC source: 0001209191-21-043535 · doc4.xml · derivative · entry 2 SULIMAN SHEHNAAZ · CIK 0001713070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2031-06-24 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:22 UTC |
SULIMAN SHEHNAAZDirector
|
GrantCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043535 · doc4.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,695 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:55 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 572 | $94.96 | $54,317.12 |
DisclosureSEC source: 0001209191-21-042812 · doc4.xml · nonDerivative · entry 2 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,708 F2 · kind: The sales reported on the transaction date of June 21, 2021 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| June 19, 2021 Filed Jun 23, 2021 21:55 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 437 | $94.63 | $41,353.31 |
DisclosureSEC source: 0001209191-21-042812 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,280 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 01:08 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
SaleCommon Stock | 1,329 | $100.00 | $132,900.00 |
DisclosureSEC source: 0001209191-21-040108 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,668 F1 · kind: The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:10 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 393 | $113.67 | $44,672.31 |
DisclosureSEC source: 0001209191-21-031378 · doc4.xml · nonDerivative · entry 2 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,717 F2 · kind: The sales reported on the transaction date of May 7, 2021 on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:11 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 363 | $113.69 | $41,269.47 |
DisclosureSEC source: 0001209191-21-031384 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,818 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:11 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Tax withholdingCommon Stock | 852 | $115.71 | $98,584.92 |
DisclosureSEC source: 0001209191-21-031383 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,200 F1 · kind: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:09 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 364 | $113.67 | $41,375.88 |
DisclosureSEC source: 0001209191-21-031376 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,775 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:14 UTC |
Huang Dennis KarlEVP & Chief Tech Ops Officer
|
SaleCommon Stock | 363 | $113.68 | $41,265.84 |
DisclosureSEC source: 0001209191-21-031390 · doc4.xml · nonDerivative · entry 1 Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,506 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes 108 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:13 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
SaleCommon Stock | 313 | $113.67 | $35,578.71 |
DisclosureSEC source: 0001209191-21-031388 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,997 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes 83 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:13 UTC |
Pinion John RichardSee Remarks
|
SaleCommon Stock | 363 | $113.69 | $41,269.47 |
DisclosureSEC source: 0001209191-21-031387 · doc4.xml · nonDerivative · entry 1 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes 248 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:12 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 142 | $113.67 | $16,141.14 |
DisclosureSEC source: 0001209191-21-031386 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,031 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes 129 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:10 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 307 | $113.68 | $34,899.76 |
DisclosureSEC source: 0001209191-21-031378 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,110 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| May 03, 2021 Filed May 5, 2021 15:32 UTC |
KAKKIS EMIL DDirector · President & CEO
|
SaleCommon Stock | 30,000 | $107.80 | $3,234,000.00 |
DisclosureSEC source: 0001209191-21-030211 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200 Disclosed balance after: 2,259,741 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.14 to $110.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 00:07 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 396 | $104.28 | $41,294.88 |
DisclosureSEC source: 0001209191-21-027881 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,417 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 21:16 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027328 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,044 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:17 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $55.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027329 · doc4.xml · derivative · entry 3 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 5,000 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on January 30, 2019 (the first anniversary of the grant date of the option or the "Option Anniversary Date") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option will fully vest on the fourth anniversary of the grant date. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:17 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 5,000 | $109.09 | $545,450.00 |
DisclosureSEC source: 0001209191-21-027329 · doc4.xml · nonDerivative · entry 2 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,139 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.35 to $110.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:17 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $55.00 | $275,000.00 |
DisclosureSEC source: 0001209191-21-027329 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:37 UTC |
Huizenga Theodore AlanSVP, Controller and PAO
|
SaleCommon Stock | 3,000 | $120.69 | $362,070.00 |
DisclosureSEC source: 0001209191-21-018872 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,544 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.68 to $120.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:42 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 707 | $138.16 | $97,679.12 |
DisclosureSEC source: 0001209191-21-017554 · doc4.xml · nonDerivative · entry 4 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,813 F5 · kind: The sales reported on this row were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:55 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $142.47 | $0.00 |
DisclosureSEC source: 0001209191-21-017567 · doc4.xml · derivative · entry 4 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-03-01 F7 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:55 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 4,572 | $138.17 | $631,713.24 |
DisclosureSEC source: 0001209191-21-017567 · doc4.xml · nonDerivative · entry 3 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,181 F3 · kind: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.16 to $138.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F6 · balance_after: Includes 139 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:55 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 4,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017567 · doc4.xml · nonDerivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,614 F2 · shares: Represents 1,530 shares of common stock and 3,106 RSUs into which previously granted performance stock units were converted on March 1, 2021 upon certification of the performance metric. The RSUs will fully vest on March 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.